Plain-English translation of NCT06188195 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether antenatal corticosteroids (a medication given to pregnant women) can help prevent severe breathing problems in newborns. Researchers have developed a prediction model that identifies pregnancies at very high risk for this complication, and this study evaluates whether giving the medication to these high-risk mothers can prevent the problem from occurring in their babies.
Severe breathing problems are a serious complication for newborns, especially those at high risk. While this medication has traditionally been used to help develop fetal lungs, this trial explores a new way it might help—by improving how fluid is cleared from the baby's lungs—and tests whether identifying at-risk pregnancies early and treating them can prevent this breathing problem altogether.
You likely qualify if…
You likely don't qualify if…
If you qualify and join the study, you would receive the prenatal treatment (antenatal corticosteroids) as part of your prenatal care. Researchers will monitor you and your baby through pregnancy and after birth to see whether the treatment helps prevent breathing problems in your newborn. Your specific visits and how long you'll be followed will be explained by the research team when you enroll.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
China